Calcification: Difference between revisions
From Wiki
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
'''MARA based network results''' |
'''MARA based network results''' |
||
*Saos-2 calcification network based on top 30 dynamic motifs |
*Saos-2 calcification network based on top 30 dynamic motifs |
||
** [https://fantom5-collaboration.gsc.riken.jp/webdav/home/m.lizio/20111011_other_expression_tables_by_timecourse/human.Saos-2.hCAGE.hg19.tpm.MARA.txt.gz |
|||
'''Related samples''' |
'''Related samples''' |
||
Revision as of 15:30, 11 October 2011
Saos-2 osteosarcoma model of Calcification/bone deposition
A human model of bone deposition/calcification using the Saos-2 osteosarcoma cell line treated with ascorbic acid and BGP was provided by Kim Summers and Margaret Davis.
Zenbu configurations and status
- Saos-2 osteosarcoma treated with ascorbic acid and BGP(COMPLETED 18 timepoints in triplicate)
Gene expression profiles
- Promoterome v1.0 expression for the Saos-2 series
- Top dynamic TFs in Saos-2 series
Motifs
- Top dynamic motifs in Saos-2 series
MARA based network results
- Saos-2 calcification network based on top 30 dynamic motifs
Related samples
- Osteosarcoma cell lines 143B/TK^(-)neo^(R) and HS-Os-1 from RIKEN BRC - contact Al Forrest
- Additional untreated timecourse is stored
- Additional timecourse using MG63 is stored
References
- First paper on Saos-2: http://www.ncbi.nlm.nih.gov/pubmed/3040234
Quality control
- Staining pictures...